Quote from Top Hair Loss Treatments on April 22, 2019, 8:41 amCassiopea has announced 12 month results of CB0301/Clascoterone/Breezula for hair loss. The results sound positive:
"statistically highly significant changes vs. vehicle were observed in all active groups with the highest change observed in the 7.5% [twice daily] group [...] These results indicate that Clascoterone stops the loss of hair and grows new hair."
"Diana Harbort, CEO of Cassiopea, said: “We are very pleased by these excellent results which show that our topical anti-androgen is efficacious in the treatment of AGA with side effects similar to placebo and importantly without any systemic side effects. Based on these results, we plan to meet with the FDA mid-year to discuss the planned six-month Phase III trials in men. Hopefully, we will begin our Phase III program in 4Q 2019."